34 East 29th Street
New York, NY 10016
Tel: (212) 686-0759
Fax: (212) 686-1479
NanoDynamics, Inc. was incorporated in the State of Delaware in 1988 to develop and commercialize an x-ray
microscope to view biochemical activities live at the molecular level. The company added “88” to its name in August, 2004
in order to avoid confusion. The company is also known as NanoD. The x-ray microscope makes use of an exceedingly
efficient x-ray generator as compared to conventional x-ray tubes, and the x-ray generator is commercially produced to
serve material evaluations and medical applications.
In 1993, the company incorporated a second area of nano-technology, the silicon-based superlattice proposed by R. Tsu.
Superlattice and quantum well as proposed by Esaki and Tsu in 1969, makes use of man-made compound
semiconductors such as GaAs, and the concept has developed into an exceedingly fertile field with 15,000 publications and
2,000 patents. Nevertheless, without the benefits of silicon processing that has powered Moore’s law of exponential
advancement, devices made from the superlattice usually cannot compete effectively against silicon devices. By extending
the man-made compounds to a silicon-based material and using silicon processing, the silicon-based superlattice can expand
the realm of silicon technology to include high temperature semiconductors and epitaxial insulators. Wide bandgap materials
and bandgap engineered optoelectronics can now be fabricated under silicon processing technologies.
Since 1993, after many rounds of small business innovative research (SBIR) Phases I, II and III awards and contracts,
mostly by the Department of Defense, the silicon-based superlattice has become sufficiently matured to provide several
new silicon materials for high temperature devices and high insulating barriers.
NanoD is collaborating with DoD agencies, defense contractors, and other commercial entities to produce x-ray instrument
and nano-electronic materials. The company has a very dedicated technical team and is led by a highly distinguished board.
The company operates laboratories in New York and works with several laboratories in other states.
Click here to contact NanoDynamics-88.
On Auger Therapy
Victor Piere Auger was a French cosmic ray physicist who discovered that in a cloud chamber, there are delta rays at the end of trace of ionizing particles, and attributed the delta rays to be low energy particles with increasing linear energy transfer, the deposition of energy to form the cloud per unit length, causing the particle to deposit all its energies in a concentrated location with large scattering angles and form the delta cloud. Since then, physicists honor Auger with all nonlinear energy transfer from charged low energy particles. They include the Proton Therapy by using external proton beams to deliver the concentrated dose for cancer patients at their tumor-bearing sites, for example, and the in situ low energy electron fluence that generates mega-Gray dose at a dimension of a few nanometers to perform molecular modifications at the DNA’s base-pair level, or the dispersion of Amyloid-beta plaque through its intercallecting diagnostic molecules for the Alzheimer’s disease. Download PDF File
On Molecular Therapy
Molecular Therapy is the therapeutic practice at the molecular level. Using various radioactive Iodines as example. I-131 delivers an electron at 97 KeV, I-125 has a K-capture mode with 149 KeV energy and I-123 has a K-capture mode of 1.4 MeV. Of the three decay modes, a single electron from I-131 provides the cellular ionizing range provides the least effective dose, while I-125 and I-123, both decay with K-capture that lead to Auger cascade and the low energy Auger electrons with in Situ mega-Gray dose that could be used for molecular modifications or molecular therapy. Note that while both I-125 and I-123 generate K-captures, the decay energy of I-125 is at an order of magnitude less than that of I-123, so that I-125 provides a relatively cleaner Auger dose and therefore more effective in therapeutic effects.
More specifically, the in Situ Auger dose could simply be induced by an external monochromatic X-ray photon beam tuned to resonantly scatter at the absorption edge of the target atom like Iodine, and by using the line-emissions of La element from a transmission X-ray tube, as described herein, to induce the Auger electrons in Situ from the non-radioactive Iodo compounds. Download PDF File
President and Founder of NanoDynamics-88, Dr C.-G. Wang has recently
completed a book which details his scientific career and the
developments, both in progress and completed in which he has been
involved during his life. To find out more and to read the book,
please click HERE